Cost-effectiveness evidence on approved cancer drugs in Ireland: the limits of data availability and implications for public accountability
{{output}}
Background: We surveyed evidence published by Ireland's National Centre for Pharmacoeconomics (NCPE) on the cost-effectiveness of cancer drugs approved for funding within the Irish public healthcare system. The purpose is threefo... ...
